Related Experiment Video
Updated: Nov 7, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
The Role of MicroRNAs in Lung Cancer Metabolism
Mohamed Iman Hidayat Nor Azizi1, Iekhsan Othman1, Rakesh Naidu1
1Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Jalan Lagoon Selatan, Bandar Sunway, Selangor Darul Ehsan 47500, Malaysia.
Abstract:
MicroRNAs (miRNAs) are short-strand non-coding RNAs that are responsible for post-transcriptional regulation of many biological processes. Their differential expression is important in supporting tumorigenesis by causing dysregulation in normal biological functions including cell proliferation, apoptosis, metastasis and invasion and cellular metabolism. Cellular metabolic processes are a tightly regulated mechanism. However, cancer cells have adapted features to circumvent these regulations, recognizing metabolic reprogramming as an important hallmark of cancer. The miRNA expression profile may differ between localized lung cancers, advanced lung cancers and solid tumors, which lead to a varying extent of metabolic deregulation. Emerging evidence has shown the relationship between the differential expression of miRNAs with lung cancer metabolic reprogramming in perpetuating tumorigenesis. This review provides an insight into the role of different miRNAs in lung cancer metabolic reprogramming by targeting key enzymes, transporter proteins or regulatory components alongside metabolic signaling pathways. These discussions would allow a deeper understanding of the importance of miRNAs in tumor progression therefore providing new avenues for diagnostic, therapeutic and disease management applications.
Insights
MicroRNAs (miRNAs) play a crucial role in lung cancer by altering cellular metabolism. Understanding miRNA-driven metabolic reprogramming offers new diagnostic and therapeutic strategies for lung cancer.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- MicroRNAs (miRNAs) are key regulators of gene expression involved in various biological processes.
- Aberrant miRNA expression contributes to tumorigenesis by disrupting normal cellular functions, including metabolism.
- Metabolic reprogramming is a hallmark of cancer, enabling tumor cells to circumvent normal regulatory mechanisms.
Purpose of the Study:
- To review the role of microRNAs in the metabolic reprogramming of lung cancer.
- To elucidate how differential miRNA expression impacts metabolic deregulation in lung cancer.
- To explore the potential of miRNAs as diagnostic and therapeutic targets in lung cancer management.
Main Methods:
- Literature review focusing on the relationship between miRNA expression and lung cancer metabolism.
- Analysis of studies investigating miRNA targeting of key metabolic enzymes, transporters, and signaling pathways.
- Synthesis of evidence linking miRNA-mediated metabolic changes to lung cancer progression.
Main Results:
- Differential miRNA expression profiles are associated with varying degrees of metabolic deregulation in localized and advanced lung cancers.
- miRNAs influence lung cancer progression by targeting critical components of metabolic pathways.
- Specific miRNAs have been identified as regulators of key enzymes and transporters involved in cancer metabolism.
Conclusions:
- MicroRNAs are significant drivers of metabolic reprogramming in lung cancer.
- Targeting miRNA-mediated metabolic alterations presents promising avenues for novel lung cancer diagnostics and therapeutics.
- A deeper understanding of miRNA functions in tumor metabolism is essential for advancing lung cancer treatment and management.
More Related Videos
08:14MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
09:06MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as A Novel Detection and Quantification Method
Published on: October 7, 2025
Related Concept Videos
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
lncRNA - Long Non-coding RNAs
PI3K/mTOR/AKT Signaling Pathway
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...